Search Results - "pulmonary artery"

Combined Methods (Formal Adjusted Indirect Comparison, Meta-Analysis and Principal Component Analysis) Comparisons of the Safety and Efficacy of Ambrisentan, Bosentan, and Sildenafil in the Patients With Pulmonary Arterial Hypertension by Xinmei Li, Te Li

Connect to this object online.

Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension - Symptoms and Impact (PAH-SYMPACT™) questionnaire in patients with chronic thromboembolic pulmonary hypertension (CTEPH): a qualitative interview study by Brooke Currie, Evan Davies, Amélie Beaudet, Larissa Stassek, Leah Kleinman

Connect to this object online.

Case Report: Neonatal Complex Congenital Heart Disease With Anomalous Origin of the Left Coronary Artery From the Right Pulmonary Artery: Analysis of Missed Diagnosis and Improvement Procedures by Zhen Bing, Leilei Liu, Rui Chen, Qian Cao, Wen Ge

Connect to this object online.

LncRNA FENDRR with m6A RNA methylation regulates hypoxia-induced pulmonary artery endothelial cell pyroptosis by mediating DRP1 DNA methylation by Xiaoying Wang, Qian Li, Siyu He, June Bai, Cui Ma, Lixin Zhang, Xiaoyu Guan, Hao Yuan, Yiying Li, Xiangrui Zhu, Jian Mei, Feng Gao, Daling Zhu

Connect to this object online.

Molecular Mechanisms in Pulmonary Hypertension and Right Ventricle Dysfunction

Subjects: “…pulmonary arterial hypertension…”
DOAB: download the publication
DOAB: description of the publication

The Xanthine Derivative KMUP-1 Inhibits Hypoxia-Induced TRPC1 Expression and Store-Operated Ca²⁺ Entry in Pulmonary Arterial Smooth Muscle Cells by Zen-Kong Dai, Yi-Chen Chen, Su-Ling Hsieh, Jwu-Lai Yeh, Jong-Hau Hsu, Bin-Nan Wu

Connect to this object online.

Perillyle alcohol and Quercetin ameliorate monocrotaline-induced pulmonary artery hypertension in rats through PARP1-mediated miR-204 down-regulation and its downstream pathway by Soodeh Rajabi, Hamid Najafipour, Saeideh Jafarinejad Farsangi, Siyavash Joukar, Ahmad Beik, Maryam Iranpour, Zeinab Kordestani

Connect to this object online.

Resveratrol downregulates TNF-α-induced monocyte chemoattractant protein-1 in primary rat pulmonary artery endothelial cells by P38 mitogen-activated protein kinase signaling by Lin JW, Yang LH, Ren ZC, Mu DG, Li YQ, Yan JP, Wang LX, Chen C

Connect to this object online.

Anesthesia management in patient with nonobstructive hypertrophic cardiomyopathy with severe mitral valvular regurgitation with severe pulmonary artery hypertension for mitral valve replacement: Its "walk a tight rope" by Nikhil N Mudgalkar

Connect to this object online.

A Nationwide multicenter registry and biobank program for deep phenotyping of idiopathic and hereditary pulmonary arterial hypertension in Korea: the PAH platform for deep phenotyping in Korean subjects (PHOENIKS) cohort by Albert Youngwoo Jang, Sungseek Kim, Su Jung Park, Hanul Choi, Pyung Chun Oh, Seyeon Oh, Kyung-Hee Kim, Kye Hun Kim, Kyunghee Byun, Wook-Jin Chung, for the PHOENIKS Investigators

Connect to this object online.

Echocardiographic Changes and Long-Term Clinical Outcomes in Pediatric Patients With Pulmonary Arterial Hypertension Treated With Bosentan for 72 Weeks: A Post-hoc Analysis From the FUTURE 3 Study by Maurice Beghetti, Maurice Beghetti, Rolf M. F. Berger, Damien Bonnet, Simon Grill, Catherine Lesage, Jean-Christophe Lemarie, D. Dunbar Ivy

Connect to this object online.

One-stage total repair of anomalous origin of right pulmonary artery from aorta by the double-flap technique, followed by coarctation repair using extended end-to-end arch reconstruction by Yu-Ning Hu, Yu-Jen Yang, Chung-Dann Kan

Connect to this object online.

circRNA CDR1as Promotes Pulmonary Artery Smooth Muscle Cell Calcification by Upregulating CAMK2D and CNN3 via Sponging miR-7-5p by Cui Ma, Rui Gu, Xiaoying Wang, Siyu He, June Bai, Lixin Zhang, Junting Zhang, Qian Li, Lihui Qu, Wei Xin, Yuan Jiang, Fei Li, Xijuan Zhao, Daling Zhu

Connect to this object online.

Successful Management of Pulmonary Arterial Hypertension by Monitoring N-Terminal Pro-B-Type Natriuretic Peptide Serum Levels in a Preterm Infant with Chronic Lung Disease: A Case Report by Keigo Seki, Satoru Iwashima, Hiroki Uchiyama, Akira Ohishi, Takamichi Ishikawa

Connect to this object online.

Switching from Beraprost to Selexipag in the Treatment of Pulmonary Arterial Hypertension: Insights from a Phase IV Study of the Japanese Registry (The EXCEL Study: EXChange from bEraprost to seLexipag Study) by Yuichi Tamura, Hiraku Kumamaru, Ichizo Tsujino, Rika Suda, Kohtaro Abe, Takumi Inami, Koshin Horimoto, Shiro Adachi, Satoshi Yasuda, Fusako Sera, Yu Taniguchi, Masataka Kuwana, Koichiro Tatsumi

Connect to this object online.

Baicalin promotes apoptosis and inhibits proliferation and migration of hypoxia-induced pulmonary artery smooth muscle cells by up-regulating A2a receptor via the SDF-1/CXCR4 signaling pathway by Xiaoying Huang, Wei Mao, Ting Zhang, Meibin Wang, Xuetao Wang, Yaozhe Li, Lin Zhang, Dan Yao, Xueding Cai, Liangxing Wang

Connect to this object online.

A comprehensive study of congenital unilateral absence of branch pulmonary artery associated with other congenital heart defects and ipsilateral non-unifocalizable major aorto-pulmonary collateral arteries: A single-center retrospective study by H Ravi Ramamurthy, Varsha Walavalkar, Satheesh Siddaiah, Sunita Maheshwari

Connect to this object online.

Correction: Baicalin promotes apoptosis and inhibits proliferation and migration of hypoxia-induced pulmonary artery smooth muscle cells by up-regulating A2a receptor via the SDF-1/CXCR4 signaling pathway by Xiaoying Huang, Wei Mao, Ting Zhang, Meibin Wang, Xuetao Wang, Yaozhe Li, Lin Zhang, Dan Yao, Xueding Cai, Liangxing Wang

Connect to this object online.

Yiqi Fumai lyophilized injection ameliorates pulmonary arterial hypertension induced right heart dysfunction through ACE2-Ang (1-7)-Mas axis and PI3K/Akt/eNOS pathway by Xiao-ying Han, Yi Zhang, Xin-yu Zhang, Hai-xia Ji, Wen-zhe Wang, Ou Qiao, Xia Li, Juan Wang, De-kun Li, Ai-chun Ju, Chang-xiao Liu, Wen-yuan Gao

Connect to this object online.

Use of the National Cancer Institute Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events to assess treatment tolerability in pulmonary arterial hypertension: qualitative patient research findings in current and former users of oral selexipag by Stacy Davis, Teresa Edwards, Lindsey Norcross, Sheri Fehnel, Amélie Beaudet, Marie Eckart, John Fastenau

Connect to this object online.